Literature DB >> 19950247

Viral load in patients infected with pandemic H1N1 2009 influenza A virus.

Kelvin K W To1, Kwok-Hung Chan, Iris W S Li, Tak-Yin Tsang, Herman Tse, Jasper F W Chan, Ivan F N Hung, Sik-To Lai, Chi-Wai Leung, Yat-Wah Kwan, Yu-Lung Lau, Tak-Keung Ng, Vincent C C Cheng, Joseph S M Peiris, Kwok-Yung Yuen.   

Abstract

Viral shedding profile of infections caused by the pandemic H1N1 2009 influenza A virus has not been reported. The aim of this study was to determine the viral load in different body sites. Viral loads of pandemic H1N1 virus in respiratory specimens, stool, urine, and serum were determined by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Respiratory specimens from patients with seasonal influenza were used as historical controls. Initial pre-treatment viral load were compared between these two groups. Serial respiratory specimens from patients with pandemic H1N1 virus infection were obtained for analysis of viral dynamics. Twenty-two pandemic H1N1 cases and 44 seasonal influenza historical controls were included. The mean initial viral load before oseltamivir therapy was 1.84 x 10(8) copies/ml for pandemic H1N1 virus compared with 3.28 x 10(8) copies/ml in seasonal influenza historical controls (P = 0.085). Among patients with pandemic H1N1 virus infection, peak viral load occurred on the day of onset of symptoms, and declined gradually afterwards, with no virus being detectable in respiratory specimens by RT-PCR 8 days and by culture 5 days after the onset of symptoms respectively, except in one patient. Pandemic H1N1 virus was detected in stool and in urine from 4/9 and 1/14 patients, respectively. Viral culture was also positive from the stool sample with the highest viral load. Younger age was associated with prolonged shedding in the respiratory tract and higher viral load in the stool. Data from this quantitative analysis of viral shedding may have implications for formulating infection control measures. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 19950247      PMCID: PMC7167040          DOI: 10.1002/jmv.21664

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  37 in total

1.  Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir.

Authors:  Guy Boivin; Zoé Coulombe; Cynthia Wat
Journal:  J Infect Dis       Date:  2003-08-05       Impact factor: 5.226

2.  Detection of BK virus and adenovirus in the urine from children after allogeneic stem cell transplantation.

Authors:  Naoki Hatakeyama; Nobuhiro Suzuki; Masaki Yamamoto; Yuki Kuroiwa; Tsukasa Hori; Nobuo Mizue; Hiroyuki Tsutsumi
Journal:  Pediatr Infect Dis J       Date:  2006-01       Impact factor: 2.129

3.  Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-05-22

4.  Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 nucleic acid extraction systems for detection of RNA and DNA respiratory viruses in nasopharyngeal aspirate samples.

Authors:  Kwok Hung Chan; Wing Cheong Yam; Chiu Mei Pang; Kit Man Chan; Siu Yan Lam; Kam Fai Lo; Leo L M Poon; J S Malik Peiris
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

5.  Severe respiratory disease concurrent with the circulation of H1N1 influenza.

Authors:  Gerardo Chowell; Stefano M Bertozzi; M Arantxa Colchero; Hugo Lopez-Gatell; Celia Alpuche-Aranda; Mauricio Hernandez; Mark A Miller
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

6.  Excretion patterns of human metapneumovirus and respiratory syncytial virus among young children.

Authors:  M-L von Linstow; J Eugen-Olsen; A Koch; T N Winther; H Westh; B Hogh
Journal:  Eur J Med Res       Date:  2006-08-30       Impact factor: 2.175

7.  Detection of human influenza virus in the stool of children.

Authors:  Susan H Wootton; David W Scheifele; Annie Mak; Martin Petric; Danuta M Skowronski
Journal:  Pediatr Infect Dis J       Date:  2006-12       Impact factor: 2.129

8.  Non-pharmaceutical interventions for pandemic influenza, international measures.

Authors:  David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan Van Tam
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

Review 9.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

10.  Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement.

Authors:  C L Ward; M H Dempsey; C J A Ring; R E Kempson; L Zhang; D Gor; B W Snowden; M Tisdale
Journal:  J Clin Virol       Date:  2004-03       Impact factor: 3.168

View more
  90 in total

1.  The Management of the 2009 pandemic Influenza A H1N1 virus infection.

Authors:  Kelvin K W To; Kwok-Yung Yuen
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

2.  Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemic.

Authors:  Navin K Vij; Christopher C Stryker; Frank P Esper; Michael R Jacobs; Blanca E Gonzalez
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

3.  Complication of corticosteroid treatment by acute Plasmodium malariae infection confirmed by small-subunit rRNA sequencing.

Authors:  Kelvin K W To; Jade L L Teng; Samson S Y Wong; Antonio H Y Ngan; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

4.  Frequent detection of pandemic (H1N1) 2009 virus in stools of hospitalized patients.

Authors:  Soo Jin Yoo; Se Jin Moon; Eun-Young Kuak; Hyeon Mi Yoo; Chang Keun Kim; Myoung-Jae Chey; Bo-Moon Shin
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

5.  The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation.

Authors:  Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Herman Tse; Candy Choi-Yi Lau; Iris Wai-Sum Li; Ivan Fan-Ngai Hung; Kwok-Hung Chan; Vincent Chi-Chung Cheng; Thomas Sik-To Lai; Patrick Chiu-Yat Woo; Eric Yuk-Tat Chan; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

6.  Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets.

Authors:  Jingjing Wang; Warren Tai; Stephanie L Angione; Amrita R John; Steven M Opal; Andrew W Artenstein; Anubhav Tripathi
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

7.  The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.

Authors:  Hui Zeng; Claudia Pappas; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

8.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

9.  Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico.

Authors:  Deborah L Thompson; Jessica Jungk; Emily Hancock; Chad Smelser; Michael Landen; Megin Nichols; David Selvage; Joan Baumbach; Mack Sewell
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

10.  Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses.

Authors:  Nathamon Ngaosuwankul; Pirom Noisumdaeng; Pisut Komolsiri; Phisanu Pooruk; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; Chariya Sangsajja; Charoen Chuchottaworn; Jeremy Farrar; Pilaipan Puthavathana
Journal:  Virol J       Date:  2010-04-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.